Hsiu‐Ming Shih

3.4k citations
58 papers · 2.9k indexed · h-index 28
Topics
Ubiquitin and proteasome pathways (10 papers)T-cell and Retrovirus Studies (6 papers)NF-κB Signaling Pathways (6 papers)
Partner nations
TaiwanUnited StatesJapan

In The Last Decade

Hsiu‐Ming Shih

58 papers receiving 2.8k citations

Peers

Hsiu‐Ming Shih
Comparison fields: 5 of 99
  • Molecular Biology 1.7k
  • Surgery 638
  • Immunology 621
  • Oncology 427
  • Cancer Research 402
Replace E P Chow with:
E P Chow United States
Eduardo H. Charreau Argentina
Véronique Kruys Belgium
Sandrina Kinet France
Gerben Zondag Netherlands
Edmund B. Rucker United States
Katalin Bánki United States
Philippe Naquet France
Josep Marı́a Estanyol Spain
John P. Capone Canada
Hsiu‐Ming Shih relative to E P Chow United States E P Chow's profile →
Citations per field
00.5×3.2×
E P Chow · 1×
Citations per year

Countries citing papers authored by Hsiu‐Ming Shih

Since Specialization
Citations

This map shows the geographic impact of Hsiu‐Ming Shih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsiu‐Ming Shih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsiu‐Ming Shih more than expected).

Fields of papers citing papers by Hsiu‐Ming Shih

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsiu‐Ming Shih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsiu‐Ming Shih. The network helps show where Hsiu‐Ming Shih may publish in the future.

Co-authorship network of co-authors of Hsiu‐Ming Shih

This figure shows the co-authorship network connecting the top 25 collaborators of Hsiu‐Ming Shih. A scholar is included among the top collaborators of Hsiu‐Ming Shih based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsiu‐Ming Shih. Hsiu‐Ming Shih is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 2
3 6
4 4
5 5
6 27
7 14
8 12
9 41
10 57
11 16
12 15
13 16
14 37
15 36
16 64
17 34
18 313
19 290
20 104

About Hsiu‐Ming Shih

Hsiu‐Ming Shih is a scholar working on Cancer Research, Immunology and Biochemistry, having authored 58 papers that have together received 2.9k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (10 papers), T-cell and Retrovirus Studies (6 papers) and NF-κB Signaling Pathways (6 papers). The work is most often cited by research in Biochemistry (215 citations), Immunology (621 citations) and Agronomy and Crop Science (280 citations). Hsiu‐Ming Shih has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Howard C. Towle, Elizabeth N. Kaytor, Jae Bum Kim, Tom Ellenberger, Yuan‐Di C. Halvorsen, Bruce M. Spiegelman, Megan E. Laurance, Laurie M. Connor, Richard H. Goodman and James R. Lundblad. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026